Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Arcadia › NPI 1508851288
Hospital

Usc Arcadia Hospital

Usc Arcadia Hospital was paid $11.65M by Medicaid between Jan 2018 and Dec 2024, across 182 billing codes. Its largest line is 0450, Emergency room services — 21% of everything it billed.

33Billing provider infoUSC ARCADIA HOSPITAL
ARCADIA, CA 91007
33aNPI1508851288assigned 09/19/2005
28Total paid$11.65M
24GClaims617,596
24DCodes billed182
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#164 of 410
Median peer was paid$6.90M
This provider vs. median1.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018101,391$1.80M
201985,855$1.65M
202060,063$1.10M
202174,504$1.48M
202292,491$1.83M
2023105,292$2.08M
2024incomplete98,000$1.72M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0450 Emergency room services 21% 64,646 58,560 $2.48M
70450 Computed tomography, head or brain; without contrast material 6.6% 8,180 7,894 $773K
74177 Computed tomography, abdomen and pelvis; with contrast material 5.9% 4,429 4,310 $685K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 5.7% 16,623 15,518 $659K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 5.1% 5,309 4,972 $600K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 3.8% 12,163 10,361 $445K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 3.5% 21,492 20,100 $409K
99281 Emergency department visit for the evaluation and management, self-limited or minor 3.4% 9,849 8,936 $392K
80053 Comprehensive metabolic panel 2.6% 36,239 33,095 $301K
96375 Therapeutic injection; each additional sequential IV push 2.4% 13,479 9,426 $277K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.3% 3,121 3,053 $272K
99199 Unlisted special service, procedure or report 2.1% 8,502 7,779 $244K
170 more codes
71045 Radiologic examination, chest; single view 2.1% 24,719 $242K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.9% 5,219 $216K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.8% 39,718 $212K
Z7502 1.7% 5,504 $196K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.5% 3,916 $172K
99283 Emergency room visit (moderate) 1.5% 2,436 $169K
72125 Computed tomography, cervical spine; without contrast material 1.2% 1,340 $143K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.0% 7,110 $120K
84484 1.0% 15,459 $118K
J3490 Unclassified drugs <1% 22,992 $104K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,442 $98K
83880 <1% 5,308 $97K
0270 <1% 17,489 $87K
0250 <1% 15,857 $83K
93971 <1% 1,179 $83K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 9,049 $77K
83690 <1% 13,456 $67K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,504 $67K
71275 Computed tomographic angiography, chest, with contrast material <1% 506 $62K
J7030 Infusion, normal saline solution , 1000 cc <1% 12,320 $62K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,598 $61K
0300 <1% 1,538 $59K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,851 $57K
86710 <1% 6,228 $53K
84703 <1% 11,353 $52K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,750 $49K
0762 <1% 554 $49K
81001 <1% 18,700 $43K
J2704 Injection, propofol, 10 mg <1% 1,316 $41K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 5,336 $40K
99221 <1% 1,556 $39K
36415 Collection of venous blood by venipuncture <1% 26,973 $36K
76801 <1% 949 $36K
87088 <1% 6,789 $36K
73564 <1% 1,670 $34K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,924 $34K
J2270 Injection, morphine sulfate, up to 10 mg <1% 5,651 $34K
0510 <1% 2,004 $33K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 270 $32K
85610 <1% 9,863 $32K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,040 $30K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,893 $30K
73630 <1% 1,609 $29K
87040 <1% 2,084 $27K
83605 <1% 3,362 $26K
90715 <1% 1,164 $26K
73610 <1% 1,279 $24K
72100 <1% 909 $23K
0272 <1% 2,756 $22K
87186 <1% 2,835 $20K
73130 <1% 969 $20K
86756 <1% 2,331 $20K
80048 Basic metabolic panel (calcium, ionized) <1% 3,423 $19K
73030 <1% 1,110 $19K
96376 <1% 1,809 $17K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 901 $15K
84702 <1% 1,847 $15K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 369 $15K
85379 <1% 2,060 $14K
G0378 Hospital observation service, per hour <1% 130 $13K
72131 <1% 109 $13K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 640 $13K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 1,406 $13K
83735 <1% 2,834 $13K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 257 $12K
82948 <1% 3,369 $12K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 2,765 $11K
70496 <1% 75 $10K
84443 Thyroid stimulating hormone (TSH) <1% 782 $9K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 832 $9K
0160 <1% 102 $8K
86901 <1% 3,095 $8K
J2060 Injection, lorazepam, 2 mg <1% 1,779 $8K
73110 <1% 411 $8K
93970 <1% 66 $8K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,682 $7K
85730 <1% 2,021 $7K
86900 <1% 3,109 $7K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 322 $7K
0636 <1% 1,539 $6K
70498 <1% 74 $6K
71046 Radiologic examination, chest; 2 views <1% 444 $6K
J1170 Injection, hydromorphone, up to 4 mg <1% 899 $6K
Z7610 <1% 573 $6K
86886 <1% 1,297 $6K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,750 $6K
J7050 Infusion, normal saline solution, 250 cc <1% 1,863 $6K
99070 <1% 541 $6K
81003 <1% 3,858 $6K
70486 <1% 55 $5K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 150 $5K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,244 $5K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 215 $5K
81002 <1% 3,261 $5K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 215 $5K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 135 $5K
0761 <1% 317 $4K
99285 Emergency room visit (most serious) <1% 31 $4K
0760 <1% 328 $4K
86850 <1% 877 $4K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 919 $4K
73080 <1% 155 $3K
73502 <1% 143 $3K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 69 $3K
80061 Lipid panel <1% 464 $3K
87070 <1% 579 $3K
86140 <1% 741 $3K
96361 Intravenous infusion, hydration; each additional hour <1% 50 $3K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 300 $2K
12001 <1% 39 $2K
73590 <1% 150 $2K
85651 <1% 969 $2K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 112 $2K
0324 <1% 138 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 650 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 560 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 311 $2K
J3475 Injection, magnesium sulfate, per 500 mg <1% 190 $2K
88312 <1% 251 $2K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 193 $2K
74018 <1% 117 $2K
A4217 Sterile water/saline, 500 ml <1% 191 $1K
71101 <1% 53 $1K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 154 $1K
29125 <1% 39 $1K
82803 <1% 104 $1K
0710 <1% 114 $1K
J1630 Injection, haloperidol, up to 5 mg <1% 244 $1K
96367 <1% 38 $1K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 13 $968.72
J1815 Injection, insulin, per 5 units <1% 87 $897.66
72040 <1% 40 $882.28
59899 <1% 78 $813.99
71010 <1% 55 $807.78
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 56 $760.87
73140 <1% 57 $648.33
76870 <1% 24 $647.88
A4649 Surgical supply; miscellaneous <1% 679 $640.34
82728 <1% 56 $591.62
J0780 Injection, prochlorperazine, up to 10 mg <1% 121 $570.30
99499 <1% 13 $545.60
82550 <1% 122 $531.77
J3010 Injection, fentanyl citrate, 0.1 mg <1% 355 $530.26
81025 <1% 146 $511.59
83615 <1% 77 $490.05
S0164 Injection, pantoprazole sodium, 40 mg <1% 42 $383.39
12011 <1% 12 $294.16
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 142 $270.37
80076 <1% 41 $248.11
J1650 Injection, enoxaparin sodium, 10 mg <1% 18 $225.23
87205 <1% 60 $212.72
73090 <1% 13 $172.84
87210 <1% 64 $148.07
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 41 $135.52
S0028 Injection, famotidine, 20 mg <1% 103 $112.27
S0077 Injection, clindamycin phosphate, 300 mg <1% 13 $111.58
J1940 Injection, furosemide, up to 20 mg <1% 15 $95.32
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 30 $80.07
82140 <1% 13 $75.73
J7510 Prednisolone oral, per 5 mg <1% 27 $65.20
59025 Fetal non-stress test <1% 14 $61.34
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 12 $54.27
J1644 Injection, heparin sodium, per 1000 units <1% 15 $51.77
84100 <1% 15 $49.19
J0690 Injection, cefazolin sodium, 500 mg <1% 16 $39.71
29515 <1% 13 $36.00
84460 <1% 15 $16.96
80354 0% 16 $0.00
0730 0% 13 $0.00
S9445 Patient education, not otherwise classified, non-physician provider, individual, per session 0% 187 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMMEJE, IKENNA (PRESIDENT, CEO)